छोड़कर सामग्री पर जाएँ

Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug

The drugmaker said that its step-down subsidiary company Aurolife Pharma has received USFDA#39;s approval to manufacture and market Diclofenac Sodium Topical Solution USP.

Read More

​ The drugmaker said that its step-down subsidiary company Aurolife Pharma has received USFDA#39;s approval to manufacture and market Diclofenac Sodium Topical Solution USP. The drugmaker said that its step-down subsidiary company Aurolife Pharma has received USFDA#39;s approval to manufacture and market Diclofenac Sodium Topical Solution USP.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी